Belatacept Pharmacokinetics in Patients with and without Infection
BKV-Associated Urothelial Carcinoma in Patients After Renal and Extrarenal Carcinoma
Characterization of Retransplantation Following Graft Failure Due to Bkvn
Coexistence of BKPyV Lytic Infection and Viral Integration in the Development of BKPyV Diseases After Renal Transplantation
Conversion from Tacrolimus to Envarsus in Rapid Metabolizers for Prevention of BK Infection
Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction
Dissecting the Intrarenal Immune Response to Viral Infected Cells in Pediatric BK Virus-associated Nephropathy (BKVAN)
Donor-Derived Cell-Free DNA Levels Risk-Stratify Polyoma BK Viremia and Associated Clinical Events After Kidney Transplantation – Preliminary Results from ADMIRAL Study
Duration and Magnitude of BK Viremia Do Not Predict Outcome in Patients After Kidney Transplantation
Efficacy of MAU868, a Novel BKV Neutralizing Monoclonal Antibody (mAb), for the Treatment of Severe BK Virus Nephropathy (BKVN) After Kidney Transplant